Susan M. Wolf, JD, is Chair of the conference planning committee. She is McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law; and Professor of Medicine at the University of Minnesota. Prof. Wolf is Chair of the Consortium on Law and Values in Health, Environment & the Life Sciences. She is an elected member of the National Academy of Medicine (NAM) and a Fellow of the American Association for the Advancement of Science. Prof. Wolf's research has been supported by the National Institutes of Health (NIH) and National Science Foundation (NSF) as well as private foundations including the Robert Wood Johnson Foundation and The Greenwall Foundation.
Sue Abderholden, MPH, is the Executive Director of NAMI Minnesota (National Alliance on Mental Illness). She has devoted her career to changing laws and attitudes that affect people with disabilities and their families. At NAMI Minnesota she has focused on the stigma surrounding mental illness and the broken system of care for children and adults with mental illnesses. Over the past twenty-five years, Ms. Abderholden has successfully fought for community and family supports and for laws that enable people with disabilities to fully participate in society. She was on the White House lawn when the Americans with Disabilities Act was signed into law, and has held positions with The Arc Minnesota, U.S. Senator Paul D. Wellstone, and the PACER Center (Minnesota’s Parent Training and Information Center).
Barbara E. Bierer, MD, is a Professor at Harvard Medical School; Senior Vice President of Research at Brigham and Women’s Hospital; Director of Regulatory Foundations, Ethics and the Law at Harvard Catalyst; Faculty Co-Director, Multi-Regional Clinical Trials (MRCT) Center; and former-Chair, Secretary’s Advisory Committee on Human Research Protections (SACHRP), Department of Health and Human Services. In addition, Dr. Bierer is Co-chair of the Partners HealthCare Committee on Conflict of Interest. In addition to her academic responsibilities, Dr. Bierer was elected to the Board of Directors of the Association for Accreditation of Human Research Protection Programs (AAHRPP), serving as its President from 2003-07, and was on the Board of Directors of the Federation of American Societies for Experimental Biology (FASEB). She was a member of the Medical and Scientific Advisory Board and, later, the Board of Directors of ViaCell, Inc. Dr. Bierer is currently a member of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Clinical Research and a member of the National Academy of Sciences Committee on Science, Technology and the Law.
Jeffrey R. Botkin, MD, MPH, is Chief of the Division of Medical Ethics & Humanities, Associate Vice President for Research Integrity, and Professor of Pediatrics at the University of Utah. He serves as the Chair of the Secretary’s Advisory Committee on Human Research Protections (SACHRP), U.S. Department of Health and Human Services (DHHS), and is a member of the FDA’s Pediatric Ethics Advisory Committee. He also serves on the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children at DHHS. Prof. Botkin was formerly Chair of the Committee on Bioethics for the American Academy of Pediatrics.
Eric G. Campbell, PhD, is Director of the Mongan Institute for Health Policy (MIHP) and a Professor at Harvard Medical School. A sociologist with expertise in survey science, Prof. Campbell conducts research relating to physician conflicts of interest and professionalism. He has received funding from organizations including the Office for Research Integrity in the U.S. Department of Health and Human Services, the National Institutes of Health, the Agency for Healthcare Research and Quality, and the Institute for Medicine.
James M. DuBois, DSc, PhD, is Steven J. Bander Professor of Medical Ethics and Professionalism, Professor of Psychology, and Director of the Center for Clinical Research Ethics at Washington University School of Medicine in St. Louis. He is an Adjunct Professor in the Albert Gnaegi Center for Health Care Ethics at Saint Louis University, where he was the inaugural Hubert Mäder Professor of Health Care Ethics and Director of the Bander Center for Medical Business Ethics. Prof. DuBois directs the NIH-funded Professionalism and Integrity in Research Program (PI Program).
Raegan W. Durant, MD, MPH, is Associate Professor of Medicine in the Division of Preventive Medicine at the University of Alabama at Birmingham. Dr. Durant’s research is focused on the relationships among social support, self-management behaviors, and hospital use for heart failure, with an eye toward developing community-based interventions to eliminate racial disparities in heart failure hospitalization rates. He also studies multi-level barriers to the recruitment of minorities into clinical trials, as possible targets for system and behavioral interventions to increase diversity in research study populations. In addition to his research, Dr. Durant serves as Medical Director at Cooper Green Mercy Health Services, a multi-specialty, publicly funded, safety-net ambulatory care center.
Carl Elliott, MD, PhD, is Professor in the Center for Bioethics and the Department of Pediatrics, and an Affiliate Faculty Member in the Department of Philosophy and the School of Journalism and Mass Communications at the University of Minnesota. He is the author or editor of seven books, including White Coat, Black Hat: Adventures on the Dark Side of Medicine (Beacon, 2010) and Better than Well: American Medicine Meets the American Dream (Norton, 2003). His articles have appeared in The New Yorker, Atlantic Monthly, London Review of Books, Mother Jones, New York Times, and New England Journal of Medicine. In 2011 the Austen Riggs Center awarded him its Erikson Prize for Excellence in Mental Health Media.
Amy Frohnmayer, MA, received her graduate degree in health psychology from Stanford University and has conducted research within the Fanconi anemia (FA) population, with a concentration on psychosocial challenges, coping strategies, and quality of life in adults with this disease. She has also worked for the Adolescent and Young Adult Oncology Program at Oregon Health and Sciences University and has collaborated with investigators at the National Institutes of Health to evaluate the role of uncertainty in decision-making related to bone marrow transplantation in families dealing with FA. She is currently pursuing a Master’s degree in counseling from Oregon State University–Cascades. She serves as a Patient Representative at the Food and Drug Administration.
Vanessa Northington Gamble MD, PhD is University Professor of Medical Humanities and Professor of Health Policy and American Studies at the George Washington University. She is the first woman and African American to hold this prestigious, endowed faculty position. She is also Professor of Health Policy in the Milken Institute School of Public Health and Professor of American Studies in the Columbian College of Arts and Sciences. Dr. Gamble is Adjunct Professor of Nursing at the University of Pennsylvania School of Nursing. Throughout her career she has worked to promote equity and justice in medicine and public health. A physician, scholar, and activist, Dr. Gamble is an internationally recognized expert on the history of American medicine, racial and ethnic disparities in health and health care, public health ethics, and bioethics. She is the author of several widely acclaimed publications on the history of race and racism in American medicine and bioethics. Public service has been a hallmark of her career. She has serviced on many boards and chaired the committee that took the lead role in the successful campaign to obtain an apology in 1997 from President Clinton for the United States Public Health Syphilis Study at Tuskegee. She is a member of the National Academy of Medicine (formerly the Institute of Medicine) and a Fellow of the Hastings Center. A proud native of West Philadelphia, Dr. Gamble received her B.A. from Hampshire College and her MD and PhD in the history and sociology of science from the University of Pennsylvania.
Paul Haluska, Jr., MD, PhD, is a medical oncologist and Global Director of Scientific Affairs, Oncology at Merck. Previously, Dr. Haluska worked at Mayo Clinic for 15 years, where his lab developed one of the largest existing collections of ovarian patient-derived xenograft (PDX) models, referred to as “Avatars.” The long-term goal of that research is to use a translational approach to develop and improve therapies in breast and ovarian cancers based on the best treatment for each patient, using her own tumor as a guide to the optimal individualized therapy. He also was the Director of the Phase I Program. Currently, he runs the investigator-initiated trials program (MISP) for Merck’s oncology franchise. Consequently, Dr. Haluska has both academic and industry perspectives on conducting research on patients and using patient tissue.
Steven Joffe, MD, MPH, is Emanuel and Robert Hart Associate Professor of Medical Ethics and Health Policy at the University of Pennsylvania, Perelman School of Medicine. A pediatric oncologist and bioethicist, he is also Director of the Penn Fellowship in Advanced Biomedical Ethics. Dr. Joffe has led NIH and foundation grants to study the roles and responsibilities of principal investigators in multicenter randomized trials, accountability in the clinical research enterprise, children’s capacity to engage in research decisions, return of individual genetic results to participants in epidemiologic cohort studies, and the integration of whole-exome sequencing technologies into the clinical care of cancer patients. He currently chairs the Children’s Oncology Group Bioethics Committee, and serves as a member of the FDA’s Pediatrics Ethics Subcommittee.
Eric W. Kaler, PhD, took office as President of the University of Minnesota in 2011. Before coming to the University, he served as Provost and Senior Vice President for Academic Affairs at Stony Brook University in New York. Pres. Kaler received his PhD in chemical engineering from the University of Minnesota and went on to become one of the nation's foremost experts in "complex fluids," which have applications in drug delivery, food processing, pharmaceuticals, and manufacturing. He is an elected member of the American Academy of Arts and Sciences and National Academy of Engineering.
Scott Y. H. Kim, MD, PhD, is a Senior Investigator in the Department of Bioethics at the National Institutes of Health Clinical Center. Dr. Kim studies research ethics, especially the ethics of involving decisionally impaired persons in research, the ethics of high-risk research, and methodological issues in empirical bioethics research. Dr. Kim is Professor of Psychiatry at the University of Michigan and has served as Co-Director of the Center for Bioethics and Social Sciences in Medicine. His work has been supported by the NIH, the American Association for Geriatric Psychiatry, the Michael J. Fox Foundation, and The Greenwall Foundation Faculty Scholars Award in Bioethics.
Bernard Lo, MD, is President and CEO of The Greenwall Foundation. He is also Professor of Medicine Emeritus and Director Emeritus of the Program in Medical Ethics at the University of California, San Francisco (UCSF). Dr. Lo chaired the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice, whose report was published in 2009. He currently serves as Co-chair of the Standards Working Group of the California Institute of Regenerative Medicine, which recommends regulations for stem cell research funded by the state of California. At the National Institutes of Health (NIH), he serves on data and safety monitoring committees for HIV vaccine trials and the Long-term Oxygen Treatment Trial. Dr. Lo serves on the Board of Directors of the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and on the Medical Advisory Panel of Blue Cross/Blue Shield.
Steven H. Miles, MD, is Professor of Medicine and Bioethics and Maas Family Endowed Chair in Bioethics at the University of Minnesota. He is an Affiliate Faculty member for the Law School's Concentration in Health Law and Bioethics. He is board certified in internal medicine. Dr. Miles has served as President of the American Society for Bioethics & Humanities and received its Distinguished Service Award. Among his other awards is the National Council of Teachers of English George Orwell Award for Distinguished Contribution to Honesty and Clarity in Public Language; American Bar Association, Section of Individual Rights and Responsibilities, Human Rights Hero; and the Sullivan-Ballou Fund Award for Human Rights.
Thomas Morgan, MD, FACMG, is Head of Human Disease Genetics at the Novartis Institutes for BioMedical Research within the Division of Biomarker Development, in which capacity he serves as a member of the Novartis Ethics Advisory Group and has exposure to clinical trial and investigator-initiated trial ethics. He has been cross-trained in clinical epidemiology, family medicine, clinical genetics, and medical biochemical genetics. As a Robert Wood Johnson Clinical Scholar at Yale, Dr. Morgan received advanced training in clinical epidemiology and health care systems and policy. He has authored over 50 publications pertaining to complex genetics research. He also served as a voting member of the Institutional Review Board at Vanderbilt University. In 2013, he was selected as Vanderbilt’s representative at the Advancing Ethical Research Conference of the Public Responsibility in Medicine & Research (PRIM&R), and he delivered the 2014 Gheen’s Foundation Visiting Scholar in Humanism in Medicine Lecture at the University of Louisville on the history of ethics in genetic research.
Kolawole Okuyemi, MD, MPH, is a Professor in the Department of Family Medicine and Community Health and Director of the Program in Health Disparities Research at the University of Minnesota. Dr. Okuyemi has devoted his career to improving the health of minorities and eliminating health disparities using pharmacological and culturally tailored behavioral interventions. He has received funding for research and educational programs from NIH and private foundations totaling $28 million, and has mentored a large number of faculty, postdoctoral fellows, and graduate and undergraduate students.
Michael T. Osterholm, PhD, MPH, is Regents Professor; McKnight Presidential Endowed Chair in Public Health; the Director of the Center for Infectious Disease Research and Policy (CIDRAP); and Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health at the University of Minnesota. He is also a Professor in the Technological Leadership Institute, College of Science and Engineering, and an Adjunct Professor in the Medical School. He is a member of the National Academy of Medicine (NAM) and the Council on Foreign Relations. He has served as a high-level advisor on issues related to bioterrorism, public health preparedness, and infectious diseases.
Richard Sharp, PhD, is Professor and Director of the Biomedical Ethics Program, the Center for Individualized Medicine Bioethics Program, and the Clinical and Translational Research Ethics Program, at the Mayo Clinic. He has studied a variety of topics in biomedical ethics, including the integration of genetic technologies into patient care, best practices for clinical ethics consultation, financial conflicts of interest, and ethical dimensions of patient advocacy. Prof. Sharp frequently advises health care organizations on ethical issues and has served on advisory committees for the National Institutes of Health, Institute of Medicine, and U.S. Environmental Protection Agency.
Robert Steinbrook, MD, is Editor-at-large and Viewpoints Editor at JAMA Internal Medicine, a contributing writer for JAMA, and Professor Adjunct of Internal Medicine at the Yale University School of Medicine. Previously, he was a Deputy Editor and national correspondent for The New England Journal of Medicine, and a medical writer for the Los Angeles Times. He is a general internist and trained in internal medicine at the University of California, San Francisco.
John E. Wagner, Jr., MD, is McKnight Presidential Chair in Childhood Cancer Research; Children's Cancer Research Fund/Hageboeck Family endowed Chair in Pediatric Oncology; Professor and Director of Blood Marrow Transplantation in the the Department of Pediatrics; Scientific Director of Clinical Research at the Stem Cell Institute; and Co-Director of the Center for Translational Medicine at the University of Minnesota. Dr. Wagner has led the University of Minnesota’s Cord Blood Transplantation Program in the treatment of adults and children and is responsible for its international prominence, having first pioneered its use in 1990 in leukemia. Dr. Wagner also specializes in Fanconi anemia and the use of stem cells in severe forms of a rare skin disease called epidermolysis bullosa, or EB.
Douglas Yee, MD, is Director of the Masonic Cancer Center, Professor of Medicine and Pharmacology, and John H. Kersey Chair in Cancer Research at the University of Minnesota. As Director of the Cancer Center, he serves as the point person for all cancer research at the University. He also treats patients with breast cancer and conducts research to improve cancer therapies.